Trademark: 86543084
Status Date
Monday, November 19, 2018
Filing Date
Monday, February 23, 2015
Published for Opposition
Tuesday, August 18, 2015
Abandoned Date
Monday, November 19, 2018
5 Oral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, Central Nervous System disease and disorders, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent for medical purposes; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
The wording "PROTRIEVE" has no meaning in a foreign language.
Nov 19, 2018
Abandonment Notice Mailed - No Use Statement Filed
Nov 19, 2018
Abandonment - No Use Statement Filed
Apr 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 16, 2018
Extension 5 Granted
Apr 12, 2018
Extension 5 Filed
Apr 12, 2018
Teas Extension Received
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Oct 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2017
Extension 4 Granted
Oct 3, 2017
Extension 4 Filed
Oct 3, 2017
Teas Extension Received
Mar 30, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 29, 2017
Automatic Update Of Assignment Of Ownership
Mar 29, 2017
Extension 3 Granted
Mar 22, 2017
Extension 3 Filed
Mar 22, 2017
Teas Extension Received
Jan 30, 2017
Teas Change Of Correspondence Received
Oct 25, 2016
Notice Of Approval Of Extension Request E-Mailed
Oct 24, 2016
Extension 2 Granted
Oct 10, 2016
Extension 2 Filed
Oct 10, 2016
Teas Extension Received
May 17, 2016
Notice Of Approval Of Extension Request E-Mailed
May 16, 2016
Extension 1 Granted
Apr 8, 2016
Extension 1 Filed
May 11, 2016
Case Assigned To Intent To Use Paralegal
Apr 8, 2016
Teas Extension Received
Oct 13, 2015
Noa E-Mailed - Sou Required From Applicant
Aug 18, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 18, 2015
Published For Opposition
Jul 29, 2015
Notification Of Notice Of Publication E-Mailed
Jul 16, 2015
Law Office Publication Review Completed
Jul 8, 2015
Assigned To Lie
Jun 23, 2015
Approved For Pub - Principal Register
Jun 18, 2015
Teas/Email Correspondence Entered
Jun 17, 2015
Correspondence Received In Law Office
Jun 17, 2015
Teas Response To Office Action Received
Jun 1, 2015
Notification Of Non-Final Action E-Mailed
Jun 1, 2015
Non-Final Action E-Mailed
Jun 1, 2015
Non-Final Action Written
May 29, 2015
Assigned To Examiner
Mar 9, 2015
New Application Office Supplied Data Entered In Tram
Feb 26, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
